Day: April 2, 2020

PORTLAND, Maine, April 02, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited product sales results for the first quarter ended March 31, 2020.Product Sales Results:Total product sales increased by approximately 11.3%, or $500,000, to approximately $4.9 million during the quarter ended March 31, 2020 versus last year’s first quarter, which ended March 31, 2019.  Total product sales increased by approximately 13.6%, or $1.7 million, to approximately $14.2 million during the trailing twelve-month period ended March 31, 2020 versus the trailing twelve-month period ended March...

IRVINE, Calif., April 02, 2020 (GLOBE NEWSWIRE) — TRI Pointe Group, Inc. (NYSE: TPH) announced today that it will release its financial results for the first quarter of 2020 shortly after the market closes on Thursday, April 23, 2020.  The Company will host a conference call on the same day to discuss the results at 2:00 PM Pacific (5:00 PM Eastern).  The call will be hosted by Doug Bauer, Chief Executive Officer, Tom Mitchell, Chief Operating Officer and Glenn Keeler, Chief Financial Officer.Those interested in participating in the call can dial-in toll free at (877) 407-3982, or (201) 493-6780 for international participants.  A webcast of the event will also be available under the Events & Presentations heading in the Investors section of the Company’s website at www.TriPointeGroup.com. A replay of the event will be available...

CHICAGO, April 02, 2020 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC) announced today that it will release results for its third quarter ending April 30, 2020 on Monday, June 8, 2020 after the market close. The company will host an investor teleconference on Wednesday, June 10, 2020 at 10:00 a.m. Central Time.Teleconference participation details will be communicated via web alert and posted on the Events page of the Company’s website approximately one week prior to the call.While Oil-Dri’s founding product was granular clay floor absorbents, it has since greatly diversified its portfolio. The Company’s mission to “Create Value from Sorbent Minerals” is supported by its wide array of consumer and business to business product offerings. In 2016, Oil-Dri celebrated its seventy-fifth year of business and looks forward...

GRAND RAPIDS, Mich., April 02, 2020 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2020 first quarter financial results on Thursday, April 30, 2020, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website.Brad Kessel, President and CEO and Steve Erickson, CFO will review the quarterly results in a conference call for investors and analysts beginning at 11:00 am ET on Thursday, April 30, 2020.To participate in the live conference call, please dial 1-866-200-8394. Also the conference call will be accessible through an audio webcast with user-controlled slides via the following event...

SAN JOSE, Calif., April 02, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report first quarter 2020 financial results on Wednesday, April 29, 2020, after the close of market.  Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company’s website at http://investor.aligntech.com.Following the press release, the Company will host a conference call to discuss its financial results.  The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio webcast live via the Internet.  To access the webcast, please visit http://investor.aligntech.com.  To access the conference call, please dial 201-689-8261 approximately fifteen minutes prior to the start of the call.An archived...

PALO ALTO, Calif., April 02, 2020 (GLOBE NEWSWIRE) — In the first quarter, we produced almost 103,000 vehicles and delivered approximately 88,400 vehicles. This is our best ever first quarter performance.Model Y production started in January and deliveries began in March, significantly ahead of schedule. Additionally, our Shanghai factory continued to achieve record levels of production, despite significant setbacks.Our net income and cash flow results will be announced along with the rest of our financial performance when we announce Q1 earnings. Our delivery count should be viewed as slightly conservative, as we only count a car as delivered if it is transferred to the customer and all paperwork is correct. Final numbers could vary by up to 0.5% or more. Tesla vehicle deliveries represent only one measure of the company’s financial...

WINNIPEG, Manitoba, April 02, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its fourth quarter and full year 2019 financial results. All amounts, unless specified otherwise, are expressed in Canadian dollars and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.Full Year 2019 and Recent Corporate HighlightsOn January 17, 2019, Kane Biotech renewed its exclusive worldwide license agreement with Rutgers University for all human, animal, and industrial applications of DispersinB®.On January 24, 2019, Kane Biotech closed and delivered a $440,000...

BASKING RIDGE, N.J., April 02, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the company has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) to facilitate the study and clinical use of its gammaCore SapphireTM non-invasive vagus nerve stimulation therapy, or nVNS, for respiratory symptoms associated with COVID-19.The EUA includes data from early clinical and non-clinical work that examined the use of the company’s VNS, including non-invasive therapy, in several pilot studies that involved patients with a variety of respiratory disorders. These studies suggest a possible benefit for patients with respiratory distress associated with COVID-19. Additionally, gammaCore’s strong safety and tolerability...

EDINBURGH, United Kingdom, April 02, 2020 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) has been closely monitoring the potential impact of the COVID-19 pandemic on its operations and announced today an update on the status of its ongoing clinical studies.  In order to help to protect the health of patients and investigators at its clinical study sites, the enrollment of new patients in its ongoing clinical studies has been temporarily paused.  Patients who are currently enrolled in NuCana’s ongoing studies are continuing to receive treatment. “This pandemic has dramatically impacted the global healthcare delivery system and altered the landscape not only for NuCana, but also for the wider biotech industry and society as a whole,” said Hugh S. Griffith, NuCana’s CEO. “This temporary pause in enrollment of new patients will help to...